ILC2s ride the Blimp to fly
Journal of Experimental Medicine · 04.05.2026 · 223 (5)
DOI: 10.1084/jem.20260323 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Experimental Medicine, online erschienen am 09.04.2026. Verfasst von Matthew R Hepworth und 1 weiteren Autor:innen. Beteiligte Einrichtung: School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester , Manches…. Hauptthemen laut MEDLINE: Positive Regulatory Domain I-Binding Factor 1. Die Arbeit nennt 16 Literaturangaben. Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
In this issue of JEM, Forster et al. (https://doi.org/10.1084/jem.20250781) report that Blimp-1 is a pivotal alarmin-activated transcription factor that is critical in controlling optimal effector cytokine secretion in ILC2 cells during type 2 immunity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biological Sciences, Faculty of Biology, Medicine and Health, Manchester Academic Health Science Centre, University of Manchester , Manchester, UK.
- Lydia Becker Institute of Immunology and Inflammation, University of Manchester , Manchester, UK.
ORCID-Profile: Matthew R Hepworth, Richard K Grencis
Förderung
- Wellcome Trust
Zitieren
APA
Hepworth, M. R., & Grencis, R. K. (2026). ILC2s ride the Blimp to fly. Journal of Experimental Medicine, 223(5). https://doi.org/10.1084/jem.20260323
Vancouver
Hepworth MR, Grencis RK. ILC2s ride the Blimp to fly. Journal of Experimental Medicine. 2026;223(5). doi:10.1084/jem.20260323
BibTeX
@article{Hepworth2026,
author = {Hepworth, Matthew R and Grencis, Richard K},
title = {ILC2s ride the Blimp to fly},
journal = {Journal of Experimental Medicine},
year = {2026},
volume = {223},
number = {5},
doi = {10.1084/jem.20260323}
}
EUVIMED